Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion type Assertion NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_head.
- NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion description "[Of the five GDPDs tested, GDPD5 was found to be significantly overexpressed in highly malignant estrogen receptor negative (ER(-)) compared with weakly malignant estrogen receptor positive (ER(+)) human breast cancer cells (p = 0.027) and breast tumors from patients (p = 0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_provenance.
- NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion evidence source_evidence_literature NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_provenance.
- NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion SIO_000772 22279038 NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_provenance.
- NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion wasDerivedFrom befree-2016 NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_provenance.
- NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_assertion wasGeneratedBy ECO_0000203 NP956150.RAN8TMAdz1fG0b7BJxhVdObt6vAJBp9luAdZ5okaxDg2Y130_provenance.